600 related articles for article (PubMed ID: 25770416)
21. Molecular chaperone functions in protein folding and proteostasis.
Kim YE; Hipp MS; Bracher A; Hayer-Hartl M; Hartl FU
Annu Rev Biochem; 2013; 82():323-55. PubMed ID: 23746257
[TBL] [Abstract][Full Text] [Related]
22. Role of molecular chaperones in neurodegenerative disorders.
Meriin AB; Sherman MY
Int J Hyperthermia; 2005 Aug; 21(5):403-19. PubMed ID: 16048838
[TBL] [Abstract][Full Text] [Related]
23. The role of heat shock proteins as chaperones on several human diseases.
Mellati AA
Saudi Med J; 2006 Sep; 27(9):1302-5. PubMed ID: 16951762
[TBL] [Abstract][Full Text] [Related]
24. Proteostasis and the Regulation of Intra- and Extracellular Protein Aggregation by ATP-Independent Molecular Chaperones: Lens α-Crystallins and Milk Caseins.
Carver JA; Ecroyd H; Truscott RJW; Thorn DC; Holt C
Acc Chem Res; 2018 Mar; 51(3):745-752. PubMed ID: 29442498
[TBL] [Abstract][Full Text] [Related]
25. Molecular chaperones: from proteostasis to pathogenesis.
Ravindran MS
FEBS J; 2018 Sep; 285(18):3353-3361. PubMed ID: 29890022
[TBL] [Abstract][Full Text] [Related]
26. In vivo aspects of protein folding and quality control.
Balchin D; Hayer-Hartl M; Hartl FU
Science; 2016 Jul; 353(6294):aac4354. PubMed ID: 27365453
[TBL] [Abstract][Full Text] [Related]
27. The neurodegenerative-disease-related protein sacsin is a molecular chaperone.
Anderson JF; Siller E; Barral JM
J Mol Biol; 2011 Aug; 411(4):870-80. PubMed ID: 21726565
[TBL] [Abstract][Full Text] [Related]
28. Molecular Chaperones' Potential against Defective Proteostasis of Amyotrophic Lateral Sclerosis.
Kinger S; Dubey AR; Kumar P; Jagtap YA; Choudhary A; Kumar A; Prajapati VK; Dhiman R; Mishra A
Cells; 2023 May; 12(9):. PubMed ID: 37174703
[TBL] [Abstract][Full Text] [Related]
29. Proteotoxic stress and inducible chaperone networks in neurodegenerative disease and aging.
Morimoto RI
Genes Dev; 2008 Jun; 22(11):1427-38. PubMed ID: 18519635
[TBL] [Abstract][Full Text] [Related]
30. Model systems of protein-misfolding diseases reveal chaperone modifiers of proteotoxicity.
Brehme M; Voisine C
Dis Model Mech; 2016 Aug; 9(8):823-38. PubMed ID: 27491084
[TBL] [Abstract][Full Text] [Related]
31. Modeling the Critical Activation of Chaperone Machinery in Protein Folding.
Theocharopoulou G; Vlamos P
Adv Exp Med Biol; 2020; 1194():351-358. PubMed ID: 32468551
[TBL] [Abstract][Full Text] [Related]
32. Molecular chaperones and proteostasis regulation during redox imbalance.
Niforou K; Cheimonidou C; Trougakos IP
Redox Biol; 2014; 2():323-32. PubMed ID: 24563850
[TBL] [Abstract][Full Text] [Related]
33. Chaperone AMPylation modulates aggregation and toxicity of neurodegenerative disease-associated polypeptides.
Truttmann MC; Pincus D; Ploegh HL
Proc Natl Acad Sci U S A; 2018 May; 115(22):E5008-E5017. PubMed ID: 29760078
[TBL] [Abstract][Full Text] [Related]
34. Walking the tightrope: proteostasis and neurodegenerative disease.
Yerbury JJ; Ooi L; Dillin A; Saunders DN; Hatters DM; Beart PM; Cashman NR; Wilson MR; Ecroyd H
J Neurochem; 2016 May; 137(4):489-505. PubMed ID: 26872075
[TBL] [Abstract][Full Text] [Related]
35. Targeting chaperones, heat shock factor-1, and unfolded protein response: Promising therapeutic approaches for neurodegenerative disorders.
Bose S; Cho J
Ageing Res Rev; 2017 May; 35():155-175. PubMed ID: 27702699
[TBL] [Abstract][Full Text] [Related]
36. Protein folding, misfolding and quality control: the role of molecular chaperones.
Papsdorf K; Richter K
Essays Biochem; 2014; 56():53-68. PubMed ID: 25131586
[TBL] [Abstract][Full Text] [Related]
37. Identification of HSPB8 modulators counteracting misfolded protein accumulation in neurodegenerative diseases.
Chierichetti M; Cerretani M; Ciammaichella A; Crippa V; Rusmini P; Ferrari V; Tedesco B; Casarotto E; Cozzi M; Mina F; Pramaggiore P; Galbiati M; Piccolella M; Bresciani A; Cristofani R; Poletti A
Life Sci; 2023 Jun; 322():121323. PubMed ID: 36574942
[TBL] [Abstract][Full Text] [Related]
38. Proteostasis in neurodegenerative diseases.
Kinger S; Jagtap YA; Kumar P; Choudhary A; Prasad A; Prajapati VK; Kumar A; Mehta G; Mishra A
Adv Clin Chem; 2024; 121():270-333. PubMed ID: 38797543
[TBL] [Abstract][Full Text] [Related]
39. Molecular chaperones antagonize proteotoxicity by differentially modulating protein aggregation pathways.
Douglas PM; Summers DW; Cyr DM
Prion; 2009; 3(2):51-8. PubMed ID: 19421006
[TBL] [Abstract][Full Text] [Related]
40. PolyQ-expanded proteins impair cellular proteostasis of ataxin-3 through sequestering the co-chaperone HSJ1 into aggregates.
Yue HW; Hong JY; Zhang SX; Jiang LL; Hu HY
Sci Rep; 2021 Apr; 11(1):7815. PubMed ID: 33837238
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
